Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution

Stock Information for Quantum-Si Incorporated

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quantum-Si Incorporated

Quantum-Si Highlights Significant Development Advancements for Proteus(TM) and Industry Leading Technology Pipeline at Investor & Analyst Day
Quantum-Si to Highlight Significant Proteus(TM) Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day
Quantum-Si Reports Third Quarter 2025 Financial Results
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.